Search results for "Febrile"

showing 10 items of 65 documents

An increase of hippocampal calretinin-immunoreactive neurons correlates with early febrile seizures in temporal lobe epilepsy

1999

Numerous studies indicate that initial precipi- tating injuries (IPI) such as febrile seizures during early childhood may play a pivotal role in the pathogenesis of temporal lobe epilepsy (TLE) and Ammon's horn sclero- sis (AHS). Previous data demonstrate an increase of hori- zontally oriented neurons in molecular layers of hip- pocampal subfields, which are immunoreactive for calre- tinin (CR-ir) and resemble Cajal-Retzius-like cells. Cajal- Retzius cells are transiently expressed in the murine de- veloping hippocampus and are critically involved in neu- ronal pattern formation. Here we investigated a potential relationship between the distribution of horizontally ori- ented calretinin-imm…

AdultPathologymedicine.medical_specialtyAdolescentHippocampusNerve Tissue ProteinsHippocampal formationHippocampusSeizures FebrilePathology and Forensic MedicineTemporal lobeCellular and Molecular NeuroscienceEpilepsyS100 Calcium Binding Protein GmedicineNeuropilHumansNeuronsSclerosisbusiness.industryDentate gyrusAge FactorsAnatomyMiddle Agedmedicine.diseaseGranule cellImmunohistochemistrymedicine.anatomical_structureEpilepsy Temporal Lobenervous systemCalbindin 2Neurology (clinical)CalretininbusinessActa Neuropathologica
researchProduct

Bickerstaff brainstem encephalitis. A case report

1992

A 33-year-old woman three weeks after a febrile illness presented with a syndrome of ophthalmoplegia, ataxia and areflexia (SOAA) that characterizes clinically both Bickerstaff and Miller Fisher syndromes. The normality of the electrophysiological tests performed, the CSF findings and the magnetic resonance images proved that the syndrome stemmed from brainstem pathology.

Adultmedicine.medical_specialtyPathologyAtaxiaNeurologyBickerstaff brainstem encephalitisDermatologyotorhinolaryngologic diseasesmedicineHumansNeuroradiologyOphthalmoplegiaReflex Abnormalmedicine.diagnostic_testbusiness.industryGeneral NeuroscienceFebrile illnessMagnetic resonance imagingSyndromeGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingPsychiatry and Mental healthEncephalitisAtaxiaFemaleNeurology (clinical)NeurosurgeryBrainstemmedicine.symptombusinessBrain StemThe Italian Journal of Neurological Sciences
researchProduct

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.

2018

Splenectomy in addition to immunotherapy with rituximab can provide quick and sometimes durable disease control in patients with splenic marginal zone lymphoma (SMZL). However, systemic chemotherapy is ultimately required in many cases. The BRISMA (Bendamustine-rituximab as first-line treatment of splenic marginal zone lymphoma)/IELSG (International Extranodal Lymphoma Study Group)36 trial is an open-label, single arm phase II study designed by the IELSG in cooperation with the Fondazione Italiana Linfomi and the lymphoma Study Association according to Simon's two-stage method. The primary endpoint was complete response rate. Fifty-six patients with SMZL diagnosis confirmed on central revis…

BendamustineAdultMalemedicine.medical_specialtyPhases of clinical researchNeutropeniaGastroenterologyDisease-Free SurvivalDrug Administration ScheduleSettore MED/15 - Malattie Del Sangue03 medical and health sciences0302 clinical medicineInternal medicinefirst-line therapyAntineoplastic Combined Chemotherapy ProtocolsMedicineBendamustine HydrochlorideHumansSplenic marginal zone lymphomabendamustineAgedbusiness.industrySplenic NeoplasmsHematologyLymphoma B-Cell Marginal ZoneMiddle Agedmedicine.diseaseLymphomaimmunochemotherapyRegimenTreatment Outcome030220 oncology & carcinogenesisbendamustine; first-line therapy; immunochemotherapy; rituximab; Splenic Marginal Zone Lymphoma; HematologySplenectomyRituximabFemaleSplenic Marginal Zone LymphomaNeoplasm Recurrence LocalbusinessRituximabFebrile neutropenia030215 immunologymedicine.drugBritish journal of haematology
researchProduct

Prospective, Observational Study To Assess The Safety Of Rituximab In Combination With Chemotherapy In Patients With Previously-Untreated Or Relapsed…

2013

Abstract Aim and Background The efficacy and safety of rituximab plus chemo (R+chemo) for first-line and relapsed B-CLL patients(pts) have been widely investigated in clinical trials and large patient cohorts, but much less is known about whether such regimens can be effectively and safely administered to unselected pts in the community setting to reflect the routine care of B-CLL pts. Therefore, this observational study was designed to characterize the type, severity and frequency of all adverse events occurring on-treatment and in the year following rituximab infusion. A secondary objective was to assess response rate (CR/nPR/PR), duration of response, disease-free survival, overall survi…

Bendamustinemedicine.medical_specialtybusiness.industryImmunologyCell BiologyHematologyNeutropeniamedicine.diseaseInterim analysisBiochemistryChemotherapy regimenGastroenterologySurgeryFludarabineInternal medicineCohortMedicineRituximabbusinessFebrile neutropeniamedicine.drugBlood
researchProduct

From smart working to smart co-working in the covid-19 era: a pilot program of cooperation around autoinflammatory diseases

2020

Introduction: The last time was signed by the pandemic diffusion of COVID-19, with an emergency area COVID-19 dedicated and the need to minimize the inflow of children and adolescents affected by chronic diseases into the hospitals. Otherwise, paediatricians had to limit visits and to consider a new setting for febrile children. Objectives: Patients affected by autoinflammatory diseases were assisted by telephonic consultations guaranteed by the paediatricians of free choice and by the paediatric rheumatologists. However, the patients frequently needed a direct clinical approach and a specialistic evaluation in the case of flares and/or abnormal laboratory parameters and adverse reactions t…

COVID-19febrile childrenautoinflammatory diseases
researchProduct

Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study.

2015

Febrile neutropenia (FN) is one of the most common adverse events associated with myelosuppressive chemotherapy for cancer treatment. The objective of this study was to describe the incidence of hospitalization due to FN in Spanish tertiary care hospitals (PINNACLE study). This epidemiological, retrospective, multicenter, nationwide study involved 119 patients from oncology units of 10 Spanish tertiary care hospitals who were admitted for FN. The primary endpoint was to assess the epidemiology and characteristics of FN. The incidence of admissions due to FN in oncology patients was 2.0% (interquartile range [IQR], 1.6–3.0). In terms of fever and absolute neutrophil count (ANC), 37.0% of the…

Cancer ResearchPediatricsmedicine.medical_specialtyChemotherapybusiness.industryIncidence (epidemiology)medicine.medical_treatmentArticlesmedicine.diseasechemotherapyPINNACLE studyfebrile neutropeniaOncologyInterquartile rangeSpainEpidemiologymedicineAbsolute neutrophil countClinical endpointcancerAdverse effectbusinessFebrile neutropeniahospitalization
researchProduct

Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukem…

2010

Abstract 207 Introduction: Chemoimmunotherapy regimens have become the treatment standard for patients with CLL. Ofatumumab is a human monoclonal antibody that targets a unique small-loop epitope on CD20 and elicits rapid and efficient in vitro complement-dependent cytotoxicity, as well as antibody-dependent cellular cytotoxicity. Recent studies demonstrated single-agent ofatumumab activity, with high overall response rates (ORR) in patients with refractory CLL. We conducted an international, randomized, parallel group, Phase II trial with two doses of ofatumumab combined with fludarabine and cyclophosphamide (FC) in previously untreated patients with CLL to evaluate the efficacy and tolera…

Cancer Researchmedicine.medical_specialtybusiness.industryMedizinHematologyNeutropeniamedicine.diseaseOfatumumabFludarabineRegimenchemistry.chemical_compoundOncologyTolerabilitychemistryChemoimmunotherapyInternal medicineImmunologymedicineRituximabbusinessFebrile neutropeniamedicine.drugClinical Lymphoma Myeloma and Leukemia
researchProduct

Has the use of antipyretics been modified after the introduction of different concentrations of ibuprofen into the market?

2014

Introduction: Due to the emergence of new pharmaceutical presentations of ibuprofen (40 mg/mL), an analysis was made on the use of antipyretics in paediatric outpatients in Spain. Patients and methods: A cross-sectional, observational, descriptive study was carried out on a sample of children under 14 years old with treated febrile syndrome, seen in the Emergency Room of the Hospital General Universitario de Valencia from November 2012 to January 2013. Results: Of the 217 children included, 144 were treated with paracetamol or ibuprofen, 69 received both drugs, and one received paracetamol and metamizol. There were 58.7% of exposures to paracetamol and 40.9% to ibuprofen. The parents decide…

Drugmedicine.medical_specialtymedia_common.quotation_subjectCombined useOff-label useIbuprofenoPediatricsRJ1-570Febrile syndromeManagement of Technology and InnovationInternal medicinemedicineAntipyreticUtilización de medicamentosAntipyretic drugsNiñosmedia_commonbusiness.industryorganic chemicalsUso «off-label»IbuprofenParacetamolAnesthesiabusinessFiebremedicine.drugAnales de Pediatría (English Edition)
researchProduct

Lack of SCN1A Mutations in Familial Febrile Seizures

2002

Summary:  Purpose: Mutations in the voltage-gated sodium channel subunit gene SCN1A have been associated with febrile seizures (FSs) in autosomal dominant generalized epilepsy with febrile seizures plus (GEFS+) families and severe myoclonic epilepsy of infancy. The present study assessed the role of SCN1A in familial typical FSs. Methods: FS families were selected throughout a collaborative study of the Italian League Against Epilepsy. For each index case, the entire coding region of SCN1A was screened by denaturant high-performance liquid chromatography. DNA fragments showing variant chromatograms were subsequently sequenced. Results: Thirty-two FS families accounting for 91 affected indiv…

GAMMA-2-SUBUNITMaleFebrile convulsionsDNA Mutational Analysismedicine.disease_causePolymerase Chain ReactionSodium ChannelsFebrileEpilepsyExonPLUSDNA Mutational AnalysisGene duplicationChildIndex caseChromatography High Pressure LiquidGeneticsChromatographyMutationIdiopathic epilepsyExonsNeurologyIon channelsHigh Pressure LiquidFemaleGeneralized epilepsy with febrile seizures plusMutationsAdultAdolescentGENERALIZED EPILEPSYNerve Tissue ProteinsSeizures FebrileSeizuresGeneticsmedicineHumansFamilybusiness.industryCONVULSIONSGene AmplificationSODIUM-CHANNELmedicine.diseaseGENEDYSFUNCTIONNAV1.1 Voltage-Gated Sodium ChannelFebrile convulsions; Genetics; Idiopathic epilepsy; Ion channels; Mutations; Adolescent; Adult; Child; Chromatography High Pressure Liquid; DNA Mutational Analysis; Exons; Female; Gene Amplification; Humans; Male; Mutation; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Polymerase Chain Reaction; Seizures Febrile; Sodium Channels; FamilyMutationMyoclonic epilepsyNeurology (clinical)businessEpilepsia
researchProduct

The Endocannabinoid System as a Therapeutic Target in Epilepsy

2008

Kainic acidbusiness.industryStatus epilepticusmedicine.diseaseGABAergic neuronEndocannabinoid systemEpilepsychemistry.chemical_compoundchemistryFebrile seizureMedicinemedicine.symptombusinessNeuroscience
researchProduct